Document is current
Any future updates will be listed below
-
Authors
Civera, Jose
de la Espriella, Rafael
Heredia, Raquel
Miñana, Gema
Santas, Enrique
Conesa, Adriana
Mollar, Anna
Sastre, Clara
Martínez, Ana
Villaescusa, Amparo
Núñez, Julio https://orcid.org/0000-0003-1672-7119
-
Funding
Funding for this research was provided by:
Universitat de Valencia
- License Information
-
More Information
Article History
Received: 24 June 2021
Accepted: 10 September 2021
First Online: 12 October 2021
Declarations
:
: All procedures were performed in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.
: Rafael de la Espriella received board speaker fees and travel expenses from Novartis, Rovi, Pfizer, Daiichi Sankyo, Astra-Zeneca, NovoNordisk, Boehringer Ingelheim, Lilly. Gema Miñana received speaker fees and travel expenses from Abbott. Enrique Santas received board speaker fees and travel expenses from Novartis, Rovi, Pfizer, Daiichi Sankyo, Astra-Zeneca, NovoNordisk, Boehringer Ingelheim. Julio Núñez received board speaker fees and travel expenses from Novartis, Rovi, Pfizer, Daiichi Sankyo, Astra-Zeneca, NovoNordisk, Boehringer Ingelheim, Lilly. All other authors declare no competing interests.
